Abstract Background Diabetic kidney disease (DKD) is a leading cause of end-stage renal failure
Reduces Inflammation: Chronic inflammation is at the root of many health problems, including skin conditions, joint pain, and cardiovascular diseases
The glucagon receptor component may partially offset this by increasing energy expenditure rather than relying solely on caloric restriction
Sulforaphane was found to prevent diabetes-induced hypertension and cardiac dysfunction in a study including hyperglycemic mice treated with or without sulforaphane (0.5 mg/kg daily for 5 days/week) for 3 months and with 3 months of further observation (Bai et al., 2013)
Clinical Application: While not FDA-approved for anti-aging or performance enhancement, IGF-1 LR3 is used off-label for tissue regeneration, metabolic enhancement, and muscle growth under clinical supervision
The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy